Pharmacotherapy of Gastropathy (Literature Review)

dc.contributor.authorDjanaev G.Yu
dc.contributor.authorKhudayberdiev Kh.I
dc.contributor.authorAskarov O.O
dc.contributor.authorSultanov S.A
dc.date.accessioned2026-01-01T10:18:01Z
dc.date.issued2023-02-18
dc.description.abstractDisruption of secretory and movement activity of the gastrointestinal tract is observed in many diseases and pathological conditions. A large arsenal of drugs is used to normalize the functions of the gastrointestinal tract. It mainly contains substances that directly affect the secretory and movement functions of the stomach and intestine, as well as the excretory function of the pancreas and liver. At the same time, they include appetite suppressants, as well as anti-vomiting and anti-vomiting drugs.
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/3401
dc.identifier.uri10.62480/tjms.2023.vol17.pp67-76
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59555
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/3401/2825
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 17 (2023): TJMS; 67-76
dc.source2770-2936
dc.subjectgastropathy
dc.subjectM-cholinoblockers
dc.subjectProton pump inhibitors pathogenesis
dc.subjectMisoprostol
dc.titlePharmacotherapy of Gastropathy (Literature Review)
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
gyu_2023_pharmacotherapy_of_gastropathy_literatur.pdf
item.page.filesection.size
265.45 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections